Research.Patient.info
Relapsed or Refractory Acute Myeloid Leukemia research hub
2 indexed studies · 0 currently recruiting
- authorisedHuman Pharmacology (Phase I)- Other
A Phase 1b Study of the Safety and Pharmacokinetics of Pivekimab Sunirine in Pediatric Subjects with Relapsed or Refractory Acute Myeloid Leukemia (AML).
This study is testing a new medicine, Pivekimab Sunirine, in children and teenagers with a type of blood cancer called Acute Myeloid Leukaemia (AML) that has come back or hasn't responded to other treatments. The main aim is to see if the medicine is safe and how it moves through the body.
Spain · Hungary · Czechia - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A Dose Finding Phase 1 Study of CC-96191 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia
This early-stage study is looking for the best dose of a new experimental drug, CC-96191, for people in the UK with acute myeloid leukaemia. This is a type of blood cancer that has come back or hasn't responded to previous treatments. It's the first time this drug is being given to humans.
France